ICD-10 updates twice a year and Post COVID-19 code

ICD-10 may be moving to biannual updates —April 1, in addition to October 1—depending on public comment . CMS and CDC jointly announced that the possibility of a regular April 1 update to ICD-10 is under consideration. CMS is taking the lead in the discussion and collection of public comment. 

By law, the current use of April 1 for an interim implementation of new ICD-10 codes is highly constrained—emerging diseases and qualifying NTAP (New Technology Add-on Payment) proposals only. As far as I know we have never had an April 1 update for procedure codes, and in 2020 the “scheduled” April 1 update, one diagnosis code to capture the use of vaping, was all but forgotten in the “unscheduled” introduction of new COVID-19 codes and the ensuing year-long scramble to update, and update, and update. We have discovered that a pandemic does not wait for arbitrary dates like April 1 and October 1—emergency updates happen when they happen. So, the idea under discussion is to broaden the use of an April 1 update to include, for example, new codes discussed at the September C&M meeting.

Read also  COVID-19: EUA (Emergency Use Authorization) for Antibody Treatment

Read also: Coding Guidelines for Injectable drugs (HCPCS codes)

More COVID-19 ICD-10-CM/PCS Codes Proposed

Both diagnosis and procedure codes for COVID-related conditions and treatment were proposed. Instead of the previous emergency updates, this time they are proposed for October 1, 2021 implementation.

A new diagnosis code, U09.9 Post COVID-19 condition, unspecified, is proposed to establish a link in the medical record between COVID-19 and conditions that persist after the person no longer has COVID-19. Examples given are chronic respiratory failure, loss of taste or loss of smell. The persistent condition is coded first, followed by the proposed new code.

Read also  CPT codes 87636 & 87637(tests for COVID-19 & flu) Coding rules

Four new procedure codes are proposed for the intravenous infusion of two additional substances that may be administered to patients hospitalized for treatment of COVID-19. The substances are Hyperimmune Globulin and High-Dose Intravenous Immune Globulin. Brand names such as Octagam 10%, GAMUNEX-C and common acronyms (HIG, hdIVIG), are proposed for the PCS Substance Key and Index, to help coders with code assignment.

Read also  When to use CS & 95 modifier in Telehealth services and COVID-19 testing

Reference:

https://www.3mhisinsideangle.com/blog-post/

FREE CPT Code Search Tool (Click Here)

MUST BUY CPT & ICD-10 CM  CODING EBOOKS 

Author

  • Jitendra M.Sc CPC

    Need expert coding advice?

    This article was written by Jitendra, CPC, a coding veteran with a decade of facility experience. Learn more about our mission on our About Us page.

    Connect with Jitendra: [%%AMCIL_PROTECT_5%%] | [%%AMCIL_PROTECT_6%%] | [%%AMCIL_PROTECT_7%%]

2 Comments

  1. Pingback: ICD-10 updates twice a year and Post COVID-19 code – medicalbilling

Leave a Reply